Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 833, pseudogene (ZNF833P) is a human gene classified as a pseudogene, meaning it is structurally similar to known protein-coding genes (zinc finger proteins) but is not believed to encode a functional protein in vivo[1][2][6]. While ZNF833P is predicted to have DNA-binding transcription factor activity and to regulate gene expression based on sequence similarity and gene ontology annotation, there is no experimental evidence confirming a biological role for this gene. It is found in the nucleus, related to the broader family of zinc finger transcription factors, which generally act by binding DNA and modulating transcription, but ZNF833P itself does not have confirmed activity and is not considered a drug target or biomarker[1][2][3][6].
None known; no evidence for targeting or mechanistic drug interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 833, pseudogene (ZNF833P).